ZEAL — Zealand Pharma A/S Cashflow Statement
0.000.00%
Last trade - 00:00
- DKK36.34bn
- DKK34.82bn
- DKK342.79m
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -572 | -847 | -1,018 | -1,202 | -704 |
Depreciation | |||||
Non-Cash Items | 141 | 22.1 | -22.8 | 151 | 177 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 7.58 | 93.3 | -211 | -9.51 | 76 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -409 | -689 | -1,212 | -942 | -426 |
Capital Expenditures | -23.5 | -25 | -22.1 | -11.7 | -23.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -28.1 | -172 | 4.01 | 293 | -1,070 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -51.7 | -197 | -18.1 | 281 | -1,094 |
Financing Cash Flow Items | -14.4 | -42.7 | -46.9 | -47.4 | -71.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 674 | 761 | 1,333 | 588 | 907 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 220 | -121 | 169 | -59.9 | -620 |